Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 5/16/25 → 8/16/25 |
Financiación
- Regeneron Pharmaceuticals: 6.006,00 US$
Study Start Up Costs Only: Quantum: A Phase 3, Randomized, Double-Masked, Active-Controlled Study of the Efficacy and Safety of 8 mg Aflibercept in Participants with Macular Edema Following Retinal Vein Occlusion
- Clevenger, Leanne (PI)